vs
Side-by-side financial comparison of LXP Industrial Trust (LXP) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.
OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $86.7M, roughly 1.7× LXP Industrial Trust). LXP Industrial Trust runs the higher net margin — 33.2% vs -21.1%, a 54.2% gap on every dollar of revenue. On growth, LXP Industrial Trust posted the faster year-over-year revenue change (-14.0% vs -19.2%). Over the past eight quarters, LXP Industrial Trust's revenue compounded faster (0.3% CAGR vs -7.5%).
LXP Industrial Trust is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality industrial real estate assets, primarily distribution centers, logistics facilities, and light industrial properties across key markets in the United States. Its tenant base covers e-commerce, third-party logistics, and advanced manufacturing sectors, delivering stable long-term returns for its investors.
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
LXP vs OPK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $86.7M | $148.5M |
| Net Profit | $28.8M | $-31.3M |
| Gross Margin | 81.5% | 43.1% |
| Operating Margin | 34.6% | -25.8% |
| Net Margin | 33.2% | -21.1% |
| Revenue YoY | -14.0% | -19.2% |
| Net Profit YoY | — | -322.8% |
| EPS (diluted) | — | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $86.7M | $148.5M | ||
| Q3 25 | $86.9M | $151.7M | ||
| Q2 25 | $87.7M | $156.8M | ||
| Q1 25 | $88.9M | $150.0M | ||
| Q4 24 | $100.9M | $183.6M | ||
| Q3 24 | $85.6M | $173.6M | ||
| Q2 24 | $85.8M | $182.2M | ||
| Q1 24 | $86.3M | $173.7M |
| Q4 25 | $28.8M | $-31.3M | ||
| Q3 25 | $36.3M | $21.6M | ||
| Q2 25 | $29.1M | $-148.4M | ||
| Q1 25 | $19.0M | $-67.6M | ||
| Q4 24 | — | $14.0M | ||
| Q3 24 | $6.3M | $24.9M | ||
| Q2 24 | $5.4M | $-10.3M | ||
| Q1 24 | $-269.0K | $-81.8M |
| Q4 25 | 81.5% | 43.1% | ||
| Q3 25 | 82.3% | 32.9% | ||
| Q2 25 | 81.9% | 31.5% | ||
| Q1 25 | 80.7% | 28.4% | ||
| Q4 24 | 85.3% | 46.1% | ||
| Q3 24 | 82.5% | 23.1% | ||
| Q2 24 | 82.0% | 28.4% | ||
| Q1 24 | 82.4% | 24.2% |
| Q4 25 | 34.6% | -25.8% | ||
| Q3 25 | 50.4% | 31.7% | ||
| Q2 25 | 33.7% | -38.3% | ||
| Q1 25 | 21.8% | -44.8% | ||
| Q4 24 | — | -18.0% | ||
| Q3 24 | 7.9% | 8.2% | ||
| Q2 24 | 6.9% | -33.9% | ||
| Q1 24 | 1.0% | -41.2% |
| Q4 25 | 33.2% | -21.1% | ||
| Q3 25 | 41.7% | 14.3% | ||
| Q2 25 | 33.2% | -94.7% | ||
| Q1 25 | 21.4% | -45.1% | ||
| Q4 24 | — | 7.6% | ||
| Q3 24 | 7.4% | 14.3% | ||
| Q2 24 | 6.3% | -5.7% | ||
| Q1 24 | -0.3% | -47.1% |
| Q4 25 | — | $-0.04 | ||
| Q3 25 | $0.12 | $0.03 | ||
| Q2 25 | $0.09 | $-0.19 | ||
| Q1 25 | $0.06 | $-0.10 | ||
| Q4 24 | — | $0.02 | ||
| Q3 24 | $0.02 | $0.03 | ||
| Q2 24 | $0.01 | $-0.01 | ||
| Q1 24 | $-0.01 | $-0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $170.4M | $364.4M |
| Total DebtLower is stronger | $1.4B | $344.0M |
| Stockholders' EquityBook value | $2.0B | $1.3B |
| Total Assets | $3.5B | $1.9B |
| Debt / EquityLower = less leverage | 0.66× | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $170.4M | $364.4M | ||
| Q3 25 | $229.7M | $412.0M | ||
| Q2 25 | $71.0M | $267.3M | ||
| Q1 25 | $70.9M | $428.8M | ||
| Q4 24 | $101.8M | $426.6M | ||
| Q3 24 | $55.0M | $400.1M | ||
| Q2 24 | $48.7M | $40.6M | ||
| Q1 24 | $293.8M | $75.6M |
| Q4 25 | $1.4B | $344.0M | ||
| Q3 25 | $1.5B | $344.2M | ||
| Q2 25 | $1.5B | $343.3M | ||
| Q1 25 | $1.5B | $439.2M | ||
| Q4 24 | $1.6B | $437.2M | ||
| Q3 24 | — | $441.0M | ||
| Q2 24 | — | $201.9M | ||
| Q1 24 | — | $350.1M |
| Q4 25 | $2.0B | $1.3B | ||
| Q3 25 | $2.1B | $1.3B | ||
| Q2 25 | $2.1B | $1.3B | ||
| Q1 25 | $2.1B | $1.3B | ||
| Q4 24 | $2.1B | $1.4B | ||
| Q3 24 | $2.1B | $1.4B | ||
| Q2 24 | $2.1B | $1.4B | ||
| Q1 24 | $2.2B | $1.3B |
| Q4 25 | $3.5B | $1.9B | ||
| Q3 25 | $3.7B | $2.0B | ||
| Q2 25 | $3.7B | $2.0B | ||
| Q1 25 | $3.8B | $2.1B | ||
| Q4 24 | $3.8B | $2.2B | ||
| Q3 24 | $3.9B | $2.3B | ||
| Q2 24 | $3.9B | $2.0B | ||
| Q1 24 | $4.2B | $2.0B |
| Q4 25 | 0.66× | 0.27× | ||
| Q3 25 | 0.72× | 0.26× | ||
| Q2 25 | 0.72× | 0.26× | ||
| Q1 25 | 0.73× | 0.33× | ||
| Q4 24 | 0.75× | 0.32× | ||
| Q3 24 | — | 0.31× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $188.7M | $-25.9M |
| Free Cash FlowOCF − Capex | — | $-28.6M |
| FCF MarginFCF / Revenue | — | -19.3% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | 6.56× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-190.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $188.7M | $-25.9M | ||
| Q3 25 | $63.5M | $-34.6M | ||
| Q2 25 | $44.3M | $-83.4M | ||
| Q1 25 | $39.0M | $-34.6M | ||
| Q4 24 | $211.2M | $-44.4M | ||
| Q3 24 | $64.6M | $-77.1M | ||
| Q2 24 | $38.5M | $-26.4M | ||
| Q1 24 | $38.9M | $-35.6M |
| Q4 25 | — | $-28.6M | ||
| Q3 25 | — | $-37.8M | ||
| Q2 25 | — | $-86.7M | ||
| Q1 25 | — | $-37.7M | ||
| Q4 24 | — | $-49.8M | ||
| Q3 24 | — | $-85.0M | ||
| Q2 24 | — | $-33.7M | ||
| Q1 24 | — | $-40.0M |
| Q4 25 | — | -19.3% | ||
| Q3 25 | — | -24.9% | ||
| Q2 25 | — | -55.3% | ||
| Q1 25 | — | -25.2% | ||
| Q4 24 | — | -27.1% | ||
| Q3 24 | — | -49.0% | ||
| Q2 24 | — | -18.5% | ||
| Q1 24 | — | -23.0% |
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 2.9% | ||
| Q3 24 | — | 4.6% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 2.6% |
| Q4 25 | 6.56× | — | ||
| Q3 25 | 1.75× | -1.60× | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 2.05× | — | ||
| Q4 24 | — | -3.17× | ||
| Q3 24 | 10.18× | -3.10× | ||
| Q2 24 | 7.09× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LXP
Segment breakdown not available.
OPK
| Services | $71.1M | 48% |
| Transfer Of Intellectual Property And Other | $33.7M | 23% |
| IE | $22.1M | 15% |
| Rayaldee | $8.8M | 6% |
| Barda Agreement | $6.8M | 5% |
| MX | $6.3M | 4% |
